Prospects for Elimination of Bancroftian Filariasis by Mass Drug Treatment in Pondicherry India: A Simulation Study

Journal of Infectious Diseases

Volumn 188, Issue 9, 2003, Pages 1371-1381

  Stolk, Wilma A ^a   Swaminathan, Subramanian ^b   Van Oortmarssen, Gerrit J ^a   Das, P K ^b   Habbema, J Dik F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VECTOR CONTROL RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; IVERMECTIN;

ARTICLE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; DRUG POTENCY; ENDEMIC DISEASE; FILARIASIS; HUMAN; INDIA; MICROFILARIA; PARASITE CONTROL; PARASITE PREVALENCE; PARASITE TRANSMISSION; PREDICTION; PRIORITY JOURNAL; PROBABILITY; SIMULATION; STATISTICAL SIGNIFICANCE;

ALBENDAZOLE; ANIMALS; COMPUTER SIMULATION; DIETHYLCARBAMAZINE; ELEPHANTIASIS, FILARIAL; FILARICIDES; HUMANS; INDIA; IVERMECTIN; MODELS, BIOLOGICAL; MODELS, STATISTICAL; PREVALENCE; WUCHERERIA BANCROFTI;

EID: 0242721026     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/378354     Document Type: Article

References (52)

1. Michael E, Bundy DAP. Global mapping of lymphatic filariasis. Parasitol Today 1997; 13:472-6.
2. Michael E, Bundy DA, Grenfell BT. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 1996; 112:409-28.
3. Elimination of lymphatic filariasis as a public health problem - resolution of the executive board of the WHO. Fiftieth World Health Assembly (Geneva), 1997. Available at: http://www.who.int/ctd/filariasis/docs/WHA _50_29. pdf (accessed 15 October 2003).
4. Ottesen EA, Duke BOL, Karam M, Behbenhani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997; 75:491-503.
5. Laigret J, Fagneaux G, Tuira E. Mass chemotherapy with spaced doses of diethylcarbamazine: effects in Tahiti on microfilaraemia due to Wuchereria bancrofti var. pacifica [in French]. Bull World Health Organ 1980; 58:779-83.
6. Balakrishnan N, Ramaiah KD, Pani SP. Efficacy of bi-annual administration of DEC in the control of bancroftian filariasis. J Commun Dis 1992; 24:87-91.
7. Kimura E, Spears GF, Singh KI, et al. Long-term efficacy of single-dose mass treatment with diethylcarbamazine citrate against diurnally subperiodic Wuchereria bancrofti: eight years' experience in Samoa. Bull World Health Organ 1992; 70:769-76.
8. Bockarie MJ, Alexander ND, Hyun P, et al. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes. Lancet 1998; 351:162-8.
9. Meyrowitsch DW, Simonsen PE. Long-term effect of mass diethylcarbamazine chemotherapy on bancroftian filariasis: results at four years after start of treatment. Trans R Soc Trop Med Hyg 1998; 92:98-103.
10. Gyapong JO. Impact of single-dose ivermectin on community microfilaria load in bancroftian filariasis infection: two years post treatment. Trans R Soc Trop Med Hyg 2000; 94:434-6.
11. Das PK, Ramaiah KD, Vanamail P, et al. Placebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India. Trans R Soc Trop Med Hyg 2001; 95:336-41.
12. Ramaiah KD, Vanamail P, Pani SP, Yuvaraj J, Das PK. The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination. Trop Med Int Health 2002; 7:1-8.
13. Schlemper BR Jr, Steindel M, Grisard EC, et al. Elimination of bancroftian filariasis (Wuchereria bancrofti) in Santa Catalina state, Brazil. Trop Med Int Health 2000; 5:848-54.
14. Cartel JL, Nguyen NL, Spiegel A, et al. Wuchereria bancrofti infection in human and mosquito populations of a Polynesian village ten years after interruption of mass chemoprophylaxis with diethylcarbamazine. Trans R Soc Trop Med Hyg 1992; 86:414-6.
15. Esterre P, Plichart C, Sechan Y, Nguyen NL. The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Trop Med Int Health 2001; 6:190-5.
16. Plaisier AP, Subramanian S, Das PK, et al. The LYMFASIM simulation program for modeling lymphatic filariasis and its control. Methods Inf Med 1998; 37:97-108.
17. Subramanian S, Stolk WA, Ramaiah KD, et al. The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India. Parasitology (in press).
18. Plaisier AP, Cao WC, van Oortmarssen GJ, Habbema JD. Efficacy of ivermectin in the treatment of Wuchereria bancrofti infection: a model-based analysis of trial results. Parasitology 1999; 119:385-94.
19. Registrar General of India and Census Commissioner. Census of India 1981, ser. 30 and 32, Pondicherry: New Delhi: Controller of Publications, 1981.
20. World Health Organization. Lymphatic filariasis: the disease and its control; fifth report of the WHO Expert Committee on Filariasis. World Health Organ Tech Rep Ser 1992; 821:1-71.
21. Dreyer G, Noroes J, Amaral F, et al. Direct assessment of the adulticidal efficacy of a single dose of ivermectin in bancroftian filariasis. Trans R Soc Trop Med Hyg 1995; 89:441-3.
22. Ottesen EA. The global programme to eliminate lymphatic filariasis. Trop Med Int Health 2000; 5:591-4.
23. Ismail MM, Jayakody RL, Weil GJ, et al. Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg 1998; 92:94-7.
24. Shenoy RK, Dalia S, John A, Suma TK, Kumaraswami V. Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations. Ann Trop Med Parasitol 1999; 93:643-51.
25. Dunyo SK, Nkrumah FK, Simonsen PE. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana. Trans R Soc Trop Med Hyg 2000; 94:205-11.
26. Dunyo SK, Nkrumah FK, Simonsen PE. Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment. Trans R Soc Trop Med Hyg 2000; 94:437-43.
27. Shenoy RK, John A, Babu BS, Suma TK, Kumaraswami V. Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations. Ann Trop Med Parasitol 2000; 94:607-14.
28. Ismail MM, Jayakody RL, Weil GJ, et al. Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg 2001; 95:332-5.
29. Dunyo SK, Simonsen PE. Ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana: follow-up after re-treatment with the combination. Trans R Soc Trop Med Hyg 2002; 96:189-92.
30. Ottesen EA. Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans. Rev Infect Dis 1985; 7:341-56.
31. Noroes J, Dreyer G, Santos A, Mendes VG, Medeiros Z, Addiss D. Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Trans R Soc Trop Med Hyg 1997; 91:78-81.
32. Figueredo-Silva J, Jungmann P, Noroes J, et al. Histological evidence for adulticidal effect of low doses of diethylcarbamazine in bancroftian filariasis. Trans R Soc Trop Med Hyg 1996; 90:192-4.
33. Jayakody RL, De Silva CSS, Weerasinghe WMT. Treatment of bancroftian filariasis with albendazole: evaluation of efficacy and adverse reactions. Trop Biomed 1993; 10:19-24.
34. Plaisier AP, Stolk WA, van Oortmarssen GJ, Habbema JD. Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection. Parasitol Today 2000; 16:298-302.
35. Newcombe RG, Altman DG. Proportions and their differences. In: Altman DG, Machin D, Bryant TN, Gardner MJ, eds. Statistics with confidence. 2nd ed. London: BMJ Books, 2000:45-56.
36. Rajagopalan PK, Das PK, Subramanian S, Vanamail P, Ramaiah KD. Bancroftian filariasis in Pondicherry, south India. I. Pre-control epidemiological observations. Epidemiol Infect 1989; 103:685-92.
37. Ramaiah KD, Das PK, Appavoo NC, et al. A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health 2000; 5:842-7.
38. Cao WC, Van der Ploeg CP, Plaisier AP, van der Sluijs IJ, Habbema JD. Ivermectin for the chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment. Trop Med Int Health 1997; 2:393-403.
39. Brown KR, Ricci FM, Ottesen EA. Ivermectin: effectiveness in lymphatic filariasis. Parasitology 2000; 121:S133-46.
40. Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology 2000; 121:S113-32.
41. Ottesen EA, Ismail MM, Horton J. The role of albendazole inprogrammes to eliminate lymphatic filariasis. Parasitol Today 1999; 15:382-6.
42. Day KP, Gregory WF, Maizels RM. Age-specific acquisition of immunity to infective larvae in a bancroftian filariasis endemic area of Papua New Guinea. Parasite Immunol 1991; 13:277-90.
43. Steel C, Guinea A, Ottesen EA. Evidence for protective immunity to bancroftian filariasis in the Cook Islands. J Infect Dis 1996; 174:598-605.
44. Michael E, Bundy DA. Herd immunity to filarial infection is a function of vector biting rate. Proc R Soc Lond B Biol Sci 1998; 265:855-60.
45. Michael E. The population dynamics and epidemiology of lymphatic filariasis. In: Pasvol G, Hoffman SL, eds. Tropical medicine: science and practice. Vol. 1: Nutman TB, ed. Lymphatic filariasis. London: Imperial College Press, 2000:41-81.
46. Centers for Disease Control and Prevention. Recommendations of the International Task Force for Disease Eradication. MMWR Morb Mortal Wkly Rep 1993; 42:1-38.
47. Ichimori K. Entomology of the filariasis control programme in Samoa, Aedes polynesiensis and Ae. samoanus. Med Entomol Zool 2001; 52:11-21.
48. Gad AM, Feinsod FM, Soliman BA, Nelson GO, Gibbs PH, Shoukry A. Exposure variables in bancroftian filariasis in the Nile Delta. J Egypt Soc Parasitol 1994; 24:439-55.
49. Southgate BA. Intensity and efficiency of transmission and the development of microfilaraemia and disease: their relationship in lymphatic filariasis. J Trop Med Hyg 1992; 95:1-12.
50. Subramanian S, Krishnamoorthy K, Ramaiah KD, Habbema JDF, Das PK, Plaisier AP. The relationship between microfilarial load in the human host and uptake and development of Wuchereria bancrofti microfilariae by Culex quinquefasciatus: a study under natural conditions. Parasitology 1998; 116:243-55.
51. Southgate BA, Bryan JH. Factors affecting transmission of Wuchereria bancrofti by anopheline mosquitoes. IV. Facilitation, limitation, proportionality and their epidemiological significance. Trans R Soc Trop Med Hyg 1992; 86:523-30.
52. Woolhouse ME. A theoretical framework for the immunoepidemiology of helminth infection. Parasite Immunol 1992; 14:563-78.